Notwithstanding your personalising of the issue, I will stick to your oft-exhorted agenda of confining the discussion to the fundamentals of the company and ask you, once again, to explain how MSB's pending funding shortfall will be addressed through payments from Teva, according to your earlier assertion of:
"As for funding I have said many times that payments are triggered on milestones being reached."
And I'll ask my question again:
Specifically - as distinct from general speculation - what payments will be triggered by what milestones over the next 12 months before the cash runs out?
Notwithstanding your personalising of the issue, I will stick to...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |